Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology*; D005947:Glucose / Q000378:metabolism*; D006892:Hydroxydopamines; D007031:Hypothalamus / Q000502:physiology; D009434:Neural Pathways; D009474:Neurons / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology; D013681:Tegmentum Mesencephali / Q000502:physiology
D006892:Hydroxydopamines; D005947:Glucose; D004298:Dopamine; D009638:Norepinephrine